Novo Nordisk A/S is a Danish multinational pharmaceutical company focused on diabetes care, medicines, and devices. Its main product is the drug semaglutide, which is used to treat diabetes under the brand name Ozempic. It markets a similar formulation for weight loss under the brand name Wegovy.
Categories
Novo Nordisk A/S (NYSE: NVO)
One of the world leaders in the production of new diabetes drugs